Lars Rebien Sørensen talks about what it means to operate a global healthcare company such as Novo Nordisk. He gives an international perspective on Obamacare, saying he believes it is undignified for anyone to go without at least basic health services. Sørensen also discusses his organization's role in the global battle against the diabetes pandemic, citing a need for continued research and development in the field of insulin medications.